期刊文献+

益智胶囊对大鼠脑缺血再灌注后海马CA1区神经元迟发性死亡及学习记忆功能的影响 被引量:1

Effects of Capsule Yizhi on the Delayed Neuronal Death in Hippocampal CA1 Region and Memory Function after Global Cerebral Ischemia in Rats
下载PDF
导出
摘要 目的 :观察益智胶囊对全脑缺血后大鼠海马CA1区神经元迟发性死亡及学习功能的影响。方法 :使用四血管闭塞 ( 4 VO)法制成大鼠急性全脑缺血再灌注模型。采用免疫组织化学方法计数脑缺血再灌注脑损伤后 1、2、4、8及 4 0d时 ,大鼠海马CA1区正常神经元数量 ;并用Morriss水迷宫观察脑缺血再灌注脑损伤后 4 0d时各组大鼠的学习记忆功能。结果 :从缺血再灌注后第 2d起 ,益智胶囊 ( 10 0mg/kg)组大鼠海马CA1区正常神经元数量明显多于缺血对照组 (P <0 0 1)。同时 ,MORRIS水迷宫法检测大鼠全脑缺血再灌注脑损伤后 4 0d时的学习记忆功能 ,益智胶囊 ( 10 0mg/kg)组大鼠明显好于缺血对照组大鼠 (P <0 0 1)。结论 :益智胶囊对全脑缺血后大鼠海马CA1区神经元具有保护作用 。 Objective:To observe the effects of Capsule Yizhi on the delayed neuronal death in hippocampal CA1 region and memory function after global cerebral ischemia in rats.Methods:The model of acute reperfusion injury after cerebral ischemia in rats was made by vertebral and carotid arteries occlusion. 1,2,4,8 and 40 days later,the neurons in hippocampal CA1 region were immunohistochemically stained and calculated.And the Morris water maze test was carried out to observe the learning and memory capacities in the 40th day.Results:The number of normal neurons was significantly higher in Capsule Yizhi(100mg/kg) group than that in the control group. Compared with the control group, Capsule Yizhi (100mg/kg) could significantly shorten time in finding the platform under the water surface in Morris water maze test.Conclusion:Capsule Yizhi had protective effects on neurons in hippocampal CA1 region,and presented promising effects on learning and memory dysfunction after global ischemia/reperfusion injury.
出处 《中药材》 CAS CSCD 北大核心 2004年第7期506-509,共4页 Journal of Chinese Medicinal Materials
基金 国家 8 63计划新药博士基金 (2 0 0 3AA2Z3 5 3 5 )
关键词 益智胶囊 脑缺血 再灌注 迟发性神经元死亡 学习记忆障碍 中药 药理 Capsule Yizhi Ischemia/reperfusion injury Delayed neuronal death Learning and memory disorder
  • 相关文献

参考文献4

二级参考文献46

  • 1Di Carlo A, et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc ,2002,50(1) : 41.
  • 2Hebert LE,et al. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord, 2001,15(4) : 169.
  • 3Fillit HM,et al. Barriers to drug discovery and development for Alzheimer disease. Alzheimer Dis Assoc Disord,2002,16 Suppl 1:S1.
  • 4Bai DL,et al. Huperzine A,a potential therapeutic agent for treatment of Alzheimer's disease. Curr Med Chem, 2000,7(3):355.
  • 5Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods, 1984,11(1):47.
  • 6Pappolla MA, et al. The neuroprotective activities of melatonin against the Alzheimer b-protein are not mediated by melatonin membrane receptors. J. Pineal Res,2002,32:135.
  • 7Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. Neurogenesis in the adult human hippocampus [ J ]. Nat Med, 1998, 4(11): 1313-7.
  • 8Gage FH. Neurogenesis in the adult brain[J]. J Neurosci, 2002, 22(3): 612-3.
  • 9Dash PK, Mach SA, Moore AN. Enhanced neurogenesis in the rodent hippocampus following traumatic brain injury[J]. J Neurosci Res,2001, 63(4): 313-9.
  • 10Marmarou A, Foda MA, van den Brink W, et al. A new model of diffuse brain injury in rats. Part 1: Pathophysiology and biomechanics[J]. J Neurosurg, 1994, 80(2): 291-300.

共引文献41

同被引文献48

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部